Summary: The Centers for Medicare & Medicaid Services modified its policy on obsolete or unreliable diagnostic tests, effective May 15, 2026. Here's what billing teams need to do.
CMS obsolete diagnostic test coverage policy is one of the more consequential policy types Medicare issues. When CMS flags a test as obsolete or unreliable, reimbursement stops — not "may stop," stops. This policy does not list specific CPT or HCPCS codes in the available data, which creates its own challenge for billing teams. You need to know what this policy category means and how to find out if tests you bill fall under it.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS / Medicare |
| Policy | Obsolete or Unreliable Diagnostic Tests |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Any specialty billing diagnostic tests to Medicare — pathology, radiology, laboratory, internal medicine, neurology, and others |
| Key Action | Audit your diagnostic test charge capture against the updated CMS policy before May 15, 2026 |
CMS Obsolete or Unreliable Diagnostic Test Coverage Criteria and Medical Necessity Requirements 2026
The Centers for Medicare & Medicaid Services maintains a category of diagnostic tests it deems either obsolete or unreliable. Both designations result in non-coverage. They are not the same thing, and the distinction matters for how you respond.
An obsolete test is one that has been replaced by a better, more accurate, or more current method. CMS will not reimburse for a test when a superior alternative exists and is widely available. An unreliable test is one where the methodology itself is considered scientifically unsound — the results don't consistently predict or diagnose what the test claims to measure.
Neither designation allows for a medical necessity argument to override the non-coverage determination. That's the critical point here. With most coverage denials, you can build a medical necessity case with documentation. With obsolete or unreliable test designations under this coverage policy, the clinical rationale doesn't matter. CMS has made a categorical determination that the test does not meet the standard for Medicare payment.
Prior authorization is not the issue with this policy type. These tests don't get denied at prior auth — they get denied on the claim. By the time you know there's a problem, you've already performed the test, and collecting from the patient is restricted under Medicare's rules if the patient wasn't given an advance beneficiary notice (ABN).
This is where your exposure lives. If a test on your charge master has been newly designated as obsolete or unreliable under the modified policy effective May 15, 2026, and your team doesn't catch it before billing, you're looking at claim denial with limited recovery options.
CMS Obsolete or Unreliable Diagnostic Test Exclusions and Non-Covered Indications
The entire premise of this policy is non-coverage. There are no covered indications for a test designated obsolete or unreliable — that's the policy. But there are a few nuances worth understanding before you write off a test entirely.
First, CMS may designate a test as obsolete for one application but not another. If the same test code is used for multiple clinical purposes, check whether the designation applies to all uses or only specific indications. This is common with older laboratory panels and certain imaging modalities.
Second, a test may be obsolete under a national policy but still covered under a local coverage determination (LCD) issued by a Medicare Administrative Contractor (MAC). National policy sets the floor; MACs can be more restrictive but cannot override a national coverage decision that permits a service. However, when a national policy declares non-coverage, no LCD can restore it.
Third, "unreliable" designations often follow peer-reviewed literature or agency-level reviews that challenge the clinical validity of a test. If your medical director or ordering physicians are still using a test that's been flagged as unreliable, this is a conversation to have now — before May 15, 2026 — not after the denials start.
Coverage Indications at a Glance
Because the available policy data does not include a specific list of covered or non-covered indications with associated codes, the table below reflects the structural framework CMS uses for this policy category. Work with your MAC or compliance officer to apply this framework to specific tests you bill.
| Category | Coverage Status | Notes |
|---|---|---|
| Tests designated as obsolete by CMS | Not Covered | Replaced by superior alternatives; no medical necessity override |
| Tests designated as unreliable by CMS | Not Covered | Scientific validity challenged; categorical denial |
| Tests covered by a conflicting LCD | Varies by MAC | National non-coverage takes precedence; confirm with your MAC |
| Tests under active clinical review | Pending | Monitor for designation changes around the May 15, 2026 effective date |
| Tests with ABN on file (patient notified) | Patient liability possible | ABN does not restore Medicare coverage — it shifts financial responsibility |
CMS Obsolete or Unreliable Diagnostic Test Billing Guidelines and Action Items 2026
The effective date of May 15, 2026 is your hard deadline. Here's what to do before then.
| # | Action Item |
|---|---|
| 1 | Pull your charge master and cross-reference it against the updated CMS policy. You need a complete list of diagnostic test codes your practice bills to Medicare. This is not optional and not a task to delegate without oversight. Someone with billing and clinical knowledge needs to do this review together. |
| 2 | Contact your MAC directly to get the current list of tests designated as obsolete or unreliable. CMS national policy sets the framework, but your MAC is your operational point of contact for claim-level questions. The MAC can confirm which specific tests are affected and whether any local nuances apply to obsolete diagnostic test billing in your region. |
| 3 | Flag any at-risk test codes in your billing system before May 15, 2026. If a test code is designated as non-covered, add a hard stop or warning in your charge capture workflow. Don't rely on memory or informal communication. |
| 4 | Update your ABN process for any tests that may still be ordered despite non-coverage. If a physician wants to order a test CMS considers obsolete or unreliable, the patient must receive an ABN before the service. Without it, you cannot bill the patient after a claim denial. This is a compliance requirement, not a billing preference. |
| 5 | Audit claims billed after the policy modification date for any tests that appear on the non-covered list. If you find claims submitted after May 15, 2026 for newly designated tests, work with your compliance officer to determine whether voluntary repayment or corrected claims are required. |
| 6 | If you're not sure which tests in your practice are affected, bring in your compliance officer or a billing consultant before the effective date. This policy type has broad reach across specialties. If your practice does high-volume diagnostic testing in pathology, neurology, or laboratory medicine, the financial exposure from missed designations can be significant. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Obsolete or Unreliable Diagnostic Tests Under This Policy
The available policy data for this CMS modification does not include a specific list of CPT, HCPCS Level II, or ICD-10-CM codes. This is not unusual for this policy category — CMS often publishes the framework and criteria without embedding a static code list, because the designated tests can be updated separately through the national coverage determination (NCD) process or through MAC-level guidance.
What this means for your billing team: You cannot rely on a single code table to know your exposure. You need to cross-reference your specific codes against:
- The CMS NCD Manual (Publication 100-03), which contains historical and current coverage decisions for specific diagnostic tests
- Your MAC's LCD database, available through the MAC's website and through the CMS Coverage Database
- Any recent transmittals or Change Requests (CRs) issued around the May 15, 2026 effective date
Where to look:
| Resource | What It Covers |
|---|---|
| CMS NCD Manual, Chapter 1 | Diagnostic tests with national coverage decisions |
| MAC LCD Database | Regional coverage determinations that may affect your tests |
| CMS Coverage Database | Searchable by CPT code, test name, or topic |
| PayerPolicy.org policy page | Version-level diffs showing exactly what changed in this modification |
If you have specific codes you're concerned about, check them individually in the CMS Coverage Database at cms.gov before May 15, 2026. Don't assume a test is covered because it was covered last month.
Why This Policy Type Deserves More Attention Than It Gets
Most billing teams focus on prior authorization changes or fee schedule updates because those have immediate, visible effects on cash flow. Obsolete and unreliable test designations are quieter — until they're not.
The pattern is consistent across CMS policy history. A test gets flagged. Practices don't update their charge capture. Claims go out. Denials come back. By then, the ABN window has closed, the patient can't be billed, and the write-off is total. This isn't a revenue cycle inefficiency — it's a compliance failure.
The real issue here is that this policy category doesn't always generate the same billing guidelines noise as a new NCD or a major CPT code change. It should. A categorical non-coverage designation for a test your practice bills 200 times a month is a bigger financial event than a 2% fee schedule reduction on the same code.
Treat this modification seriously. Treat the May 15, 2026 effective date as a hard stop for your review process, not a suggested timeline.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.